Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Echinococcus granulosus | cpg binding protein | 0.0029 | 0.0156 | 0.2122 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.0156 | 0.2333 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Leishmania major | 3-oxoacyl-ACP reductase, putative | 0.0113 | 0.0658 | 0.5 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.0113 | 0.0658 | 0.5 |
Schistosoma mansoni | 3-oxoacyl-[ACP] reductase | 0.0113 | 0.0658 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.0156 | 0.2333 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.1663 | 1 | 1 |
Leishmania major | pteridine reductase 1 | 0.0113 | 0.0658 | 0.5 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.1663 | 1 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0031 | 0.016 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Leishmania major | oxidoreductase-like protein | 0.0113 | 0.0658 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0189 | 0.2833 |
Onchocerca volvulus | 0.0113 | 0.0658 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0189 | 0.2635 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.0147 | 0.1842 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0113 | 0.0658 | 1 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.1663 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0189 | 0.2524 |
Trichomonas vaginalis | helicase, putative | 0.0006 | 0.0018 | 0.0018 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Echinococcus multilocularis | 3 oxoacyl acyl carrier protein reductase | 0.0113 | 0.0658 | 1 |
Trypanosoma brucei | pteridine reductase 1 | 0.0113 | 0.0658 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0113 | 0.0658 | 0.5 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0113 | 0.0658 | 0.5 |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein reductase | 0.0113 | 0.0658 | 1 |
Toxoplasma gondii | 3-ketoacyl-(acyl-carrier-protein) reductase | 0.0113 | 0.0658 | 0.0373 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.1663 | 1 | 1 |
Entamoeba histolytica | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0113 | 0.0658 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.1663 | 1 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0021 | 0.0268 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0031 | 0.016 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.1663 | 1 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0147 | 0.2187 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Onchocerca volvulus | 0.0113 | 0.0658 | 1 | |
Loa Loa (eye worm) | retinol dehydrogenase 12 | 0.0113 | 0.0658 | 1 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0113 | 0.0658 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0059 | 0.0334 | 0.505 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.0658 | 1 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.1663 | 1 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.0029 | 0.0156 | 0.2122 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0113 | 0.0658 | 1 |
Schistosoma mansoni | dihydropteridine reductase | 0.0113 | 0.0658 | 1 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0113 | 0.0658 | 0.5 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0113 | 0.0658 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.0147 | 0.185 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0113 | 0.0658 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0189 | 0.2635 |
Toxoplasma gondii | short chain dehydrogenase family protein, putative | 0.0113 | 0.0658 | 0.0373 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0113 | 0.0658 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0113 | 0.0658 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0189 | 0.2833 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0006 | 0.0018 | 0.0018 |
Toxoplasma gondii | 2,4-dienoyl CoA reductase 2, peroxisomal family protein | 0.0113 | 0.0658 | 0.0373 |
Trichomonas vaginalis | hypothetical protein | 0.1663 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0.0018 | 0.0018 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.